NO20080002L - Formuleringer av konjugerte ostrogener og bazedoxifen - Google Patents

Formuleringer av konjugerte ostrogener og bazedoxifen

Info

Publication number
NO20080002L
NO20080002L NO20080002A NO20080002A NO20080002L NO 20080002 L NO20080002 L NO 20080002L NO 20080002 A NO20080002 A NO 20080002A NO 20080002 A NO20080002 A NO 20080002A NO 20080002 L NO20080002 L NO 20080002L
Authority
NO
Norway
Prior art keywords
bazedoxifene
conjugated estrogens
formulations
salt
estrogens
Prior art date
Application number
NO20080002A
Other languages
English (en)
Inventor
Arwinder Nagi
Ramarao S Chatlapalli
Lawrence Van Pelt
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080002(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20080002L publication Critical patent/NO20080002L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Det beskrives faste doseringsformuleringer som inneholder konjugerte østrogener og bazedoxifen eller et salt derav. I enkelte utførelsesformer inkluderer blandingene en kjerne som omfatter konjugerte østrogener og minst ett overtrekk som omfatter bazedoxifen eller et salt derav.
NO20080002A 2005-06-29 2008-01-02 Formuleringer av konjugerte ostrogener og bazedoxifen NO20080002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29
PCT/US2006/025348 WO2007002823A2 (en) 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene

Publications (1)

Publication Number Publication Date
NO20080002L true NO20080002L (no) 2008-03-12

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080002A NO20080002L (no) 2005-06-29 2008-01-02 Formuleringer av konjugerte ostrogener og bazedoxifen

Country Status (19)

Country Link
US (1) US20070003623A1 (no)
EP (1) EP1898888A2 (no)
JP (1) JP2008545012A (no)
KR (1) KR20080031037A (no)
CN (1) CN101252921A (no)
AR (1) AR054806A1 (no)
AU (1) AU2006263638A1 (no)
BR (1) BRPI0612586A2 (no)
CA (1) CA2613102A1 (no)
CR (1) CR9597A (no)
EC (1) ECSP078057A (no)
IL (1) IL188223A0 (no)
NI (1) NI200700331A (no)
NO (1) NO20080002L (no)
PA (1) PA8684501A1 (no)
PE (1) PE20070188A1 (no)
RU (1) RU2395286C2 (no)
TW (1) TW200738283A (no)
WO (1) WO2007002823A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732528A1 (en) * 2004-04-08 2006-12-20 Wyeth Bazedoxifene acetate solid dispersion formulations
JP2010511062A (ja) * 2006-11-29 2010-04-08 ワイス エルエルシー エストロゲン／ｓｅｒｍおよびエストロゲン／プロゲスチン二層錠剤
RU2009125413A (ru) * 2007-01-12 2011-02-20 Вайет (Us) Композиции таблетка-в-таблетке
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
ES2436841T3 (es) 2009-10-27 2014-01-07 Wyeth Llc Formulaciones de bazedoxifeno con antioxidantes
NZ602955A (en) * 2010-04-20 2015-02-27 Cipla Ltd Pharmaceutical composition comprising efavirenz
US8615061B2 (en) * 2010-07-29 2013-12-24 Entropic Communications, Inc. Method and apparatus for cross polarization and cross satellite interference cancellation
BR112013029199B1 (pt) * 2011-05-13 2022-02-08 Eb Ip Hybritabs B.V. Dispositivo de distribuição de dois fármacos
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬***组合物
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AU5957500A (en) * 1999-07-06 2001-01-22 Endorecherche Inc. Methods of treating and/or suppressing weight gain
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
BR0311774A (pt) * 2002-06-13 2007-05-08 Wyeth Corp regimes de tratamento com bazedoxifeno
TW200536845A (en) * 2004-04-07 2005-11-16 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
JP2007532560A (ja) * 2004-04-07 2007-11-15 ワイス バゼドキシフェンアセテートの結晶多形
US7504394B2 (en) * 2004-04-08 2009-03-17 Wyeth Bazedoxifene ascorbate
EP1732528A1 (en) * 2004-04-08 2006-12-20 Wyeth Bazedoxifene acetate solid dispersion formulations

Also Published As

Publication number Publication date
JP2008545012A (ja) 2008-12-11
TW200738283A (en) 2007-10-16
NI200700331A (es) 2009-02-16
WO2007002823A2 (en) 2007-01-04
AR054806A1 (es) 2007-07-18
PE20070188A1 (es) 2007-03-16
IL188223A0 (en) 2008-03-20
BRPI0612586A2 (pt) 2010-11-23
RU2395286C2 (ru) 2010-07-27
US20070003623A1 (en) 2007-01-04
PA8684501A1 (es) 2007-01-17
KR20080031037A (ko) 2008-04-07
WO2007002823A3 (en) 2007-08-09
ECSP078057A (es) 2008-01-23
AU2006263638A1 (en) 2007-01-04
RU2007148071A (ru) 2009-08-10
EP1898888A2 (en) 2008-03-19
CN101252921A (zh) 2008-08-27
CA2613102A1 (en) 2007-01-04
CR9597A (es) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
NO20082376L (no) Farmasoytiske sammensetninger
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
BRPI0407373A (pt) Espuma hidro-alcoólica formando espuma em filme
NO20071944L (no) Hydrolysestabil beleggingsmiddelsammensetning
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
HK1104823A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
EP1797077A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF
MEP34308A (en) Oral formulations of cladribine
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application